Response to: Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma' by Chheda et al. Issue 3 (14th March 2023)

Record Type:: Journal Article
Title:: Response to: Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma' by Chheda et al. Issue 3 (14th March 2023)
Main Title:: Response to: Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma' by Chheda et al
Authors:: Immisch, Lena
Papafotiou, George
Popp, Oliver
Mertins, Philipp
Blankenstein, Thomas
Willimsky, Gerald
Abstract:
Is Part Of:: Journal for immunotherapy of cancer. Volume 11:Issue 3(2023)
Journal:: Journal for immunotherapy of cancer
Issue:: Volume 11:Issue 3(2023)
Issue Display:: Volume 11, Issue 3 (2023)
Year:: 2023
Volume:: 11
Issue:: 3
Issue Sort Value:: 2023-0011-0003-0000
Page Start:
Page End:
Publication Date:: 2023-03-14
Subjects:: Immunotherapy, Adoptive -- Antigens, Neoplasm -- Immunotherapy
Cancer -- Immunotherapy -- Periodicals
Cancer -- Immunological aspects -- Periodicals
Tumors -- Immunological aspects -- Periodicals
Immunotherapy -- Periodicals
616.99406105
Journal URLs:: http://www.immunotherapyofcancer.org ↗
https://jitc.bmj.com/ ↗
http://link.springer.com/ ↗
DOI:: 10.1136/jitc-2023-006784 ↗
Languages:: English
ISSNs:: 2051-1426
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 26309.xml